Knowledge/Skills:
1. To recognize, screen and manage patients with HIV:
a.Demonstrate knowledge about the pathophysiology, natural history, presenting signs and symptoms and associated opportunistic infections in patients with HIV
b.Describe risk factors for perinatal transmission of HIV, tests for screening and confirmatory diagnosis and indications for referral including asymptomatic HIV infected patients
c.Describe the staging of HIV infection, the use of laboratory parameters (e.g., CD4 counts), and general treatment modalities including chemoprophylaxis.
d.Co-manage patients with HIV with other specialists and refer for management of complications (e.g., pregnant patients, AIDS-related malignancies)
e.Understand how to prevent transmission of HIV.
f. Understand ethical, cultural, socioeconomic aspects of illness
g.Have a basic understanding and familiarity of medications used to treat HIV and be aware of common side effects.
h.Understand legal and governmental regulations and the impact of cost containment of medicine
i. Demonstrate ability to work and communicate with physicians and non-physicians in a collaborative manner
2. Understand the pathogenesis of infectious diseases, and the various local and systemic host-defense mechanisms
3. Become familiar with the clinical features of common infectious diseases, specifically, upper and lower respiratory tract infections, urinary tract infections, sexually transmitted diseases, gastrointestinal infections, CNS infections, bone and joint infections, septicemias, AIDS
4. Become familiar with the in vitro spectrum, pharmacology and major toxicity of important antimicrobial agents, e.g., penicillins, cephalosporins, aminoglycosides, tetracyclines, clindamycin, erythromycin, trimethoprim-sulfamethoxazole, guinolones, major anti-fungal and anti-TB drugs, antiviral and antiparasitic drugs
5. Understand the rational use of antimicrobial agents taking into consideration the toxicity, reported efficacy in various clinical situations, in vitro antimicrobial susceptibility data, pharmacology, cost and relative value of alternate agents